| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 01/03/2003 | WO2003000643A1 Nitrate ester derivatives useful for preparing drugs for epilepsy |
| 01/03/2003 | WO2003000295A2 Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors |
| 01/03/2003 | WO2003000289A1 Composition comprising a pde-4 inhibitor and h1-receptor antagonist and the use thereof for the manufacture of a medicament for the treatment of respiratory diseases |
| 01/03/2003 | WO2003000267A1 Amino nicotinate derivatives as glucokinase (glk) modulators |
| 01/03/2003 | WO2003000262A1 Vinyl phenyl derivatives as glk activators |
| 01/03/2003 | WO2003000249A1 Function regulator for retinoid relative receptor |
| 01/03/2003 | WO2003000247A1 Carbamates of 2-heterocyclic-1,2-ethanediols |
| 01/03/2003 | WO2003000198A2 Selective neuronal nitric oxide synthase inhibitors |
| 01/03/2003 | WO2003000181A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/03/2003 | WO2002088101A3 Inhibitors of bace |
| 01/03/2003 | WO2002066020A3 Modulation of gsk-3beta activity and its different uses |
| 01/03/2003 | CA2455288A1 Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors |
| 01/03/2003 | CA2451673A1 Substituted aromatic ethers as inhibitors of glycine transport |
| 01/03/2003 | CA2451625A1 Substituted n-acyl-aniline derivatives, the preparation thereof and the use thereof as pharmaceutical compositions |
| 01/03/2003 | CA2451354A1 Herbicidal substituted pyridines, their preparation, and their use as herbicides and plant growth regulators |
| 01/03/2003 | CA2451249A1 Amino nicotinate derivatives as glucokinase (glk) modulators |
| 01/03/2003 | CA2450758A1 Composition comprising a pde-4 inhibitor and h1-receptor antagonist and the use thereof for the manufacture of a medicament for the treatment of respiratory diseases |
| 01/03/2003 | CA2450475A1 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/02/2003 | US20030004353 Process for preparing integrin antagonist intermediates |
| 01/02/2003 | US20030004344 Thrombin or factor Xa inhibitors |
| 01/02/2003 | US20030004339 Therapy for benign prostatic hyperplasia |
| 01/02/2003 | US20030004192 Using cyanoguanidine compound; anticancer agents |
| 01/02/2003 | US20030004189 Pharmaceutical uses and synthesis of nicotinanilide-N-oxides |
| 01/02/2003 | US20030004157 Neurokinin antagosnist receptor |
| 01/02/2003 | US20030004150 New analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them |
| 01/02/2003 | US20030004137 Muscle relaxants, controlling immunology, strokes, antidiabetic agents |
| 01/02/2003 | US20030003396 Reflection, protective or covering layers which can be written on or read by blue, red or infrared light |
| 01/02/2003 | US20030003049 Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation |
| 01/02/2003 | EP1271581A2 Electrolyte composition, photoelectric conversion device and photo-electrochemical cell |
| 01/02/2003 | EP1270582A1 Triphenylphosphine derivative, production process therefor, palladium complex thereof, and process for producing biaryl derivative |
| 01/02/2003 | EP1270580A1 Antimicrobial acesulfame complexes, their preparation and their use |
| 01/02/2003 | EP1270570A1 Amide compounds and use thereof |
| 01/02/2003 | EP1270558A1 "Compound for the treatment of atherosclerotic-thrombotic pathological conditions" |
| 01/02/2003 | EP1270551A1 Urea derivatives with antiproteolytic activity |
| 01/02/2003 | EP1270535A2 Method to synthesise substituted aromatic compounds |
| 01/02/2003 | EP1268498A1 Cardioprotective phosphonates and malonates |
| 01/02/2003 | EP1268469A1 N-(heterocyclyl)benzene or pyridine sulphonamides as antithrombotic agents and anticoagulants |
| 01/02/2003 | EP1268455A2 Piperazine derivatives |
| 01/02/2003 | EP1268454A1 Succinoylamino heterocycles as inhibitors of a-beta protein production |
| 01/02/2003 | EP1268443A1 2-hydroxy-mutilin carbamate derivatives for antibacterial use |
| 01/02/2003 | EP1268430A1 Chemical complex compprising a pyridine carboxy derivative and an h2 histamine receptor antagonist |
| 01/02/2003 | EP1268429A1 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 01/02/2003 | EP1268428A2 Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade |
| 01/02/2003 | EP1268427A1 Aminopyridines and their use as anticonvulsants and sodium channel blockers |
| 01/02/2003 | EP1268412A1 Sulphonamido-substituted bridged bicycloalkyl derivatives |
| 01/02/2003 | EP1268051A2 Dosing form for reagents, use of said dosing form in organic chemical synthesis and production of said dosing form |
| 01/02/2003 | EP1098879A4 Processes for producing highly pure nicotinamide |
| 01/02/2003 | EP1030831A4 Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides |
| 01/02/2003 | EP0915859B1 Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands |
| 01/02/2003 | EP0891341B1 1,3,4-oxadiazine derivatives and their use as pesticides |
| 01/02/2003 | EP0804431B9 GLYCOPROTEIN IIb/IIIa ANTAGONISTS |
| 01/02/2003 | EP0751939B9 Naphthylamides as central nervous system agents |
| 01/02/2003 | EP0630366B1 Substituted heterocyclic derivatives useful as platelet aggregation inhibitors |
| 01/01/2003 | CN1097592C Slfonic acid amide derivatives with herbicides activity |
| 01/01/2003 | CN1097591C Process for preparing pyrimidine derivatives |
| 12/31/2002 | US6500956 Method for the catalytic production of substituted bipyridyl derivatives |
| 12/31/2002 | US6500863 Interleukin binding inhibitors such as n-(2-hydroxyl-3-amino sulfonyl-4-chlorophenyl)-n'-(2-bromophenyl)urea, used for prophylaxis of chemokine mediated diseases |
| 12/31/2002 | US6500855 Nitrogen containing aromatic heterocycles with ortho-substituted p1 groups; anticoagulants |
| 12/31/2002 | US6500852 Inhibitors of bacterial NAD synthetase |
| 12/31/2002 | US6500849 Administering antiinflammatory, antiproliferative, nootropic or antigrowth agents, such as 6-(1-dodecynyl)-2-pyridine-carboxaldehyde and enantiomorphs to mammals; alzheimers disease |
| 12/31/2002 | US6500832 Administering enzyme inhibitors as viricides for prophylaxis of viral diseases such as aquired immune deficiency syndrome |
| 12/31/2002 | US6500825 Substituted 2-aminoacetamides and the use thereof |
| 12/31/2002 | US6500823 Energy deficiency of the cell caused by parp inhibition, in diabetes complications, in oxygen deficient status of the heart and brain, in neurodegenerative diseases, in the treatment of autoimmune and/or viral diseases |
| 12/31/2002 | US6500803 Factor VIIa inhibitors |
| 12/31/2002 | US6500503 Cyclohexane derivatives, liquid crystal compositions comprising the same and liquid crystal display devices |
| 12/27/2002 | WO2002102787A2 Novel sulfonic acid derivatives |
| 12/27/2002 | WO2002102782A2 QUINAZOLINE DERIVATIVES which PROMOTE THE RELEASE OF PARATHYROID_HORMONE |
| 12/27/2002 | WO2002102779A1 Process for the preparation of 4-chloropyridine-n-oxides |
| 12/27/2002 | WO2002102778A1 Phenylpyridine carbonyl piperazine derivative |
| 12/27/2002 | WO2002102766A2 Combretastatin a-3 prodrug |
| 12/27/2002 | WO2002102380A1 Monocyclic or bicyclic carbocycles and heterocycles as factor xa inhibitors |
| 12/27/2002 | WO2002072540A3 Improved methods of ortho alkylation |
| 12/27/2002 | WO2001079174A8 A pyridine-1-oxide derivative, and process for its transformation into pharmaceutically effective compounds |
| 12/27/2002 | CA2448298A1 Phenylpyridine carbonyl piperazine derivative |
| 12/27/2002 | CA2429113A1 Monocyclic or bicyclic carbocycles and heterocycles as factor xa inhibitors |
| 12/27/2002 | CA2418102A1 Combretastatin a-3 prodrug |
| 12/26/2002 | US20020198423 Convenient and efficient suzuki-miyaura cross-coupling catalyzed by a palladium/diazabutadiene system |
| 12/26/2002 | US20020198400 Synthesis of 3-amino-3-aryl propanoates |
| 12/26/2002 | US20020198383 For use in regioselective and enantioselective alkylations of allylic substrates |
| 12/26/2002 | US20020198381 Herbicidal pyridine compounds |
| 12/26/2002 | US20020198378 For therapy of retroviral infection, e.g., an HIV infection |
| 12/26/2002 | US20020198346 Suzuki coupling reaction of vinyl-phenylboronic acid and 2-bromopyridine in presence of alkali metallic base and tetrakis/triphenylphosphine/palladium to form styrenepyridine monomer |
| 12/26/2002 | US20020198241 Inhibiting bacterial growth in humans and nonhuman mammals by administering to the patient an antibacterially effective dose of hydroxamic acid derivatives containing carbamoyl groups |
| 12/26/2002 | US20020198238 Bipyridyl compounds with specific physical properties are potent and selective cyclooxygenase-2 (COX-2) inhibitor |
| 12/26/2002 | US20020198220 Process for the preparation of arylethanolamine derivatives having an anti-obesity and anti-diabetic properties |
| 12/26/2002 | US20020198219 2-pyridinamine compositions and related methods |
| 12/26/2002 | US20020198207 Novel Hexanoic acid derivatives |
| 12/26/2002 | US20020198200 Alpha-acyl- and alpha-heteroatom-substituted benzene acetamide glucokinase activators |
| 12/26/2002 | US20020198199 Such as 2-(2-(N-((4-aminoiminomethylphenyl)methyl)-3-(3-aminophenyl)-6-(N,N -dimethylhydrazino)-1-oxypyridinyl))acetami de which inhibit serine proteases for preventing and treating thrombotis |
| 12/26/2002 | US20020198195 New oxybenzamide derivatives useful for inhibiting factor Xa or VIIa |
| 12/26/2002 | US20020198184 Matrix metalloproteinase inhibitor is useful as an anticancer agent, angiogenesis inhibitor, a tumor cell infiltration inhibitor or a tumor metastasis inhibitor; inflammatory diseases, osteoarthritis, rheumatoid arthritis |
| 12/26/2002 | US20020195585 Liquid crystalline materials containing perfluoroalkyl and alkenyl tail groups |
| 12/25/2002 | CN1387561A Composition and method for bleaching substrate |
| 12/25/2002 | CN1387531A Pyrazolo [4,3-d] pyrimidine derivs. |
| 12/25/2002 | CN1387515A Oxime O-ether compounds and fungicides for agricultural and horticultural use |
| 12/25/2002 | CN1387509A Substd. N-phenyl-2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivs. which elevate pyruvate dehydrogenase activity |
| 12/25/2002 | CN1387508A N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them |
| 12/25/2002 | CN1386737A Antifibrosis pyridinone medicine and its prepaing process |
| 12/25/2002 | CN1386736A Process for preparing nicotinic acid |
| 12/24/2002 | US6498275 Use of compounds for the elevation of pyruvate dehydrogenase activity |